Kobe Hospital Planning iPS Treatment of Retinal Disease
Newsfrom JapanSociety Lifestyle Science Technology
Kobe, Dec. 10 (Jiji Press)--Kobe City Eye Hospital has filed an application for approval on a clinical research project to produce photoreceptor cells from induced pluripotent stem, or iPS, cells, and transplant them into patients suffering from retinitis pigmentosa, an intractable eye disease.
The project will be the first of its kind in the world.
The hospital, also known as the Kobe Eye Center, said Monday it has filed the application with a committee of Osaka University.
Following screenings by the university and the health ministry, the hospital, located in Kobe, Hyogo Prefecture, western Japan, aims to conduct the first transplant surgery in fiscal 2020, which starts next April.
Retinitis pigmentosa causes photoreceptor cells, which sense light, to gradually degenerate. Patients suffering from the retinal disease, for which there is no fundamental treatment, experience symptoms such as a narrowing of the visual field and deterioration of vision.
[Copyright The Jiji Press, Ltd.]